Abstract:Background The recently identified phenomenon of double-stranded RNA (dsRNA)-mediated gene activation (RNAa) has been studied extensively, as it is present in humans, mice, and Caenorhabditis elegans , suggesting that dsRNA-mediated RNAa is an evolutionarily conserved mechanism. Previous studies have shown that dsP21-322 can induce tumor suppressor gene p21 expression in several human cancer cells. Nonetheless, the role of dsRNAs in the activation of gene expression, including their target molecules and associated key factors, remains poorly understood. Methods Oligonucleotides were used to overexpress dsRNAs and dsControl. Real-time PCR and Western blotting were used to detect corresponding mRNA and protein expression, respectively. Fluorescence microscopy was used to examine the kinetics of dsRNA subcellular distribution. Luciferase reporter assays were performed to verify dsRNA target molecules. Chromatin immunoprecipitation (ChIP) assays were carried out to determine whether histone modification and other associated key factors are involved in saRNA-mediated p21 expression. Results We demonstrated that dsRNA-mediated p21 induction in human cell lines is a common phenomenon. This process occurs at the transcriptional level, and the complementary p21 promoter is the intended dsRNA target. Additionally, ChIP assays indicated that p21 activation was accompanied by an increased enrichment of AGO1 and the trimethylation of histone H3K4 at dsRNA-targeted genomic sites. Conclusion These data systematically reveal the mechanistic and functional aspects of ncRNA-mediated p21 activation in human cancer cells, which may be a useful tool to analyze gene function and aid in the development of novel drug targets for cancer therapeutics.

Role of Human Noncoding Rnas in the Control of Tumorigenesis

The Non-Coding RNA Llme23 Drives the Malignant Property of Human Melanoma Cells

tRNA-derived small RNAs (tsRNAs): establishing their dominance in the regulation of human cancer

TRPS1 drives heterochromatic origin refiring and cancer genome evolution

Human DBR1 Modulates the Recycling of Snrnps to Affect Alternative RNA Splicing and Contributes to the Suppression of Cancer Development

The RNA-binding protein HuR in human cancer: A friend or foe?

Demystifying the Mechanistic and Functional Aspects of P21 Gene Activation with Double-Stranded RNAs in Human Cancer Cells

Dependency Of Prostate Cancer On Hnrnpl And Its Associated Rnas

The Role and Mechanism of PVT1 in Promoting Human Cancer Progression

The human RNA surveillance factor UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma

The Role Of Human Endogenous Retroviral Long Terminal Repeat Sequences In Human Cancer

Screening and identification of human polypyrimidine tract-binding protein-associated splicing factor(PSF)-binding long non-coding RNAs

RNAi, microRNAs, and human disease

Noncoding RNAs Regulating p53 and c-Myc Signaling

Activation of Src and transformation by an RPTPα splice mutant found in human tumours

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

Human antigen R and drug resistance in tumors

Prohibitin 2 orchestrates long noncoding RNA and gene transcription to accelerate tumorigenesis

Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response

Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer

VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer